Photoacoustic Micro-Imaging system for Shared Tumor Imaging Resource at Roswell P
Roswell P 共享肿瘤成像资源的光声微成像系统
基本信息
- 批准号:8247498
- 负责人:
- 金额:$ 59.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-15 至 2013-05-14
- 项目状态:已结题
- 来源:
- 关键词:AnatomyAnimal Disease ModelsAnimalsApplications GrantsAwarenessBlood flowBuffaloesCollaborationsCommunitiesComputer softwareData SetDisorder by SiteFacultyFee-for-Service PlansFunctional ImagingFundingGrowthHemoglobinImageImage AnalysisImageryImaging technologyInstitutesInstitutionKidneyLiverLymphaticMalignant - descriptorMeasuresMedicineMetastatic LesionMolecularMolecular TargetMorphologyNational Center for Research ResourcesNew YorkResearchResearch PersonnelResolutionResourcesRoswell Park Cancer InstituteSecureSentinel Lymph Node MappingServicesSystemTechnologyUnited States National Institutes of HealthUniversitiesbasecancer therapydesigninstrumentinterestmeetingsmolecular imagingnanoparticleoutreach programprogramstumoruser-friendly
项目摘要
DESCRIPTION (provided by applicant): The purpose of this NCRR Shared Instrument Grant application is to secure funding to purchase a Small Animal Photoacoustic Imaging system (Vevo(R)LAZR) for the Shared Tumor Imaging Resource (STIR) at Roswell Park Cancer Institute (RPCI). The STIR at RPCI provides customized scientific and technical small animal imaging services on a fee for service basis to NIH funded investigators at RPCI, the State University of New York at Buffalo (SUNY-Buffalo) and neighboring academic institutions in Western New York. Since 2005, the STIR has seen a steady growth in its utilization as a result of increased awareness of its imaging technologies achieved through active collaborations with institutional faculty and educational outreach programs instituted by STIR and RPCI. However, this positive change has also highlighted the need for state- of-the-art imaging technology to meet the expanding needs of RPCI research community. The Vevo LAZR platform is a high sensitivity system specifically designed for small animal imaging at a high resolution. In addition
to anatomic or morphologic assessment of tumors, the system allows for molecular functional imaging of the tumor microenvironment in small animal models of disease. The sophisticated software platform allows for visualization and quantitative analysis of imaging datasets in an efficient and user-friendly manner. With the increased interest in personalized medicine and molecular targeted therapies for cancer, several NIH-funded programs at RPCI and SUNY-Buffalo are focused on understanding the changes in the tumor microenvironment during malignant progression and following therapy. These projects, some of which have been detailed in this application, will utilize the Vevo(R)LAZR system to (i) detect occult metastatic lesions in
disease sites such as the kidney and liver, (ii) assess longitudinal changes in tumor morphology following treatment, (iii) visualize and quantify changes in tumor blood flow, (iv) map sentinel lymph nodes and lymphatics, (v) measure parameters such as oxygenation and hemoglobin saturation in tumors, and, (vi) investigate tumor-targeting ability of multifunctional nanoparticle. The availability of a user-friendly, portable imaging system at STIR would enable its users to effectively combine high-throughput anatomic imaging with quantitative, functional molecular imaging of tumors. Acquisition of the photoacoustic imaging system will not only enable STIR to meet the existing demand for this imaging technology but also facilitate further growth of STIR by increasing its imaging services and technologies available to researchers.
PUBLIC HEALTH RELEVANCE: A high-resolution, high sensitivity photoacoustic imaging system is requested for the Shared Tumor Imaging Resource at Roswell Park Cancer Institute (RPCI). The availability of a user-friendly, portable imaging system would enable multiple NCI/NIH-funded investigators at RPCI to effectively combine high throughput anatomic imaging with quantitative, functional molecular imaging for cancer research applications.
描述(由申请人提供):本NCRR共享仪器赠款申请的目的是获得资金,为罗斯韦尔公园癌症研究所(RPCI)的共享肿瘤成像资源(STIR)购买一台小动物光声成像系统(Vevo(R)LAZR)。RPCIA的STIR以服务费的形式向RPCINIH资助的研究人员、纽约州立大学布法罗分校(SUNY-Buffalo)和邻近的纽约西部学术机构提供定制的科学和技术小动物成像服务。自2005年以来,STIR的使用率稳步增长,这是因为人们对其成像技术的认识有所提高,这是通过与机构教职员工的积极合作以及STIR和RPCI制定的教育推广计划实现的。然而,这一积极的变化也突显了对最先进的成像技术的需求,以满足RPCI研究界不断扩大的需求。Vevo LAZR平台是专门为小动物高分辨率成像而设计的高灵敏度系统。此外
为了对肿瘤进行解剖或形态评估,该系统允许在疾病的小动物模型中对肿瘤微环境进行分子功能成像。复杂的软件平台允许以高效和用户友好的方式对成像数据集进行可视化和定量分析。随着人们对癌症的个性化药物和分子靶向治疗的兴趣与日俱增,美国国立卫生研究院资助的几个项目在RPCI和纽约州立大学水牛城分校专注于了解肿瘤在恶性进展和后续治疗过程中微环境的变化。这些项目,其中一些已在本申请中详细说明,将利用Vevo(R)LAZR系统:(I)在
其主要功能包括:(1)测量肿瘤的病变部位,如肾脏和肝脏;(2)评估治疗后肿瘤形态的纵向变化;(3)可视化和量化肿瘤血流量的变化;(4)绘制前哨淋巴结和淋巴管的图谱;(5)测量肿瘤中的氧合和血红蛋白饱和度等参数;(6)研究多功能纳米颗粒的肿瘤靶向能力。在STIR上提供用户友好的便携式成像系统将使其用户能够有效地将高通量解剖成像与肿瘤的定量、功能分子成像结合在一起。收购光声成像系统不仅将使STIR满足现有对该成像技术的需求,还将通过增加其可供研究人员使用的成像服务和技术,促进STIR的进一步发展。
公共卫生相关性:罗斯威尔公园癌症研究所(RPCI)的共享肿瘤成像资源需要一个高分辨率、高灵敏度的光声成像系统。用户友好的便携式成像系统的可用性将使RPCINCI/NIH资助的多名研究人员能够有效地将高通量解剖成像与定量、功能分子成像结合起来,用于癌症研究应用。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines.
- DOI:10.1038/nnano.2014.130
- 发表时间:2014-08
- 期刊:
- 影响因子:38.3
- 作者:
- 通讯作者:
Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer.
多模式成像指导前列腺癌血管靶向的临床前试验。
- DOI:10.18632/oncotarget.4463
- 发表时间:2015-09-15
- 期刊:
- 影响因子:0
- 作者:Kalmuk J;Folaron M;Buchinger J;Pili R;Seshadri M
- 通讯作者:Seshadri M
Photoacoustic monitoring of tumor and normal tissue response to radiation.
- DOI:10.1038/srep21237
- 发表时间:2016-02-17
- 期刊:
- 影响因子:4.6
- 作者:Rich LJ;Seshadri M
- 通讯作者:Seshadri M
Photoacoustic imaging of salivary glands.
唾液腺的光声成像。
- DOI:10.1364/boe.6.003157
- 发表时间:2015
- 期刊:
- 影响因子:3.4
- 作者:Rich,LaurieJ;Seshadri,Mukund
- 通讯作者:Seshadri,Mukund
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mukund Seshadri其他文献
Mukund Seshadri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mukund Seshadri', 18)}}的其他基金
Radiation-induced Salivary Gland Vascular Injury: Mechanisms and Interventions
辐射引起的唾液腺血管损伤:机制和干预措施
- 批准号:
10701306 - 财政年份:2022
- 资助金额:
$ 59.6万 - 项目类别:
Acquisition of a 7T MR scanner for Translational Imaging Research at Roswell Park
购买一台 7T MR 扫描仪用于罗斯威尔公园的转化成像研究
- 批准号:
10176803 - 财政年份:2021
- 资助金额:
$ 59.6万 - 项目类别:
Radiogenomic Credentialing of Head and Neck Cancer Models
头颈癌模型的放射基因组学认证
- 批准号:
10529301 - 财政年份:2020
- 资助金额:
$ 59.6万 - 项目类别:
Radiogenomic Credentialing of Head and Neck Cancer Models
头颈癌模型的放射基因组学认证
- 批准号:
10310511 - 财政年份:2020
- 资助金额:
$ 59.6万 - 项目类别:
Non-invasive assessment of salivary gland function: Translational Studies
唾液腺功能的无创评估:转化研究
- 批准号:
9082643 - 财政年份:2016
- 资助金额:
$ 59.6万 - 项目类别:
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer
维生素 D 对厄洛替尼口腔癌化学预防效果的影响
- 批准号:
9257368 - 财政年份:2016
- 资助金额:
$ 59.6万 - 项目类别:
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer
维生素 D 对厄洛替尼口腔癌化学预防效果的影响
- 批准号:
10215646 - 财政年份:2016
- 资助金额:
$ 59.6万 - 项目类别:
DEVELOPMENT AND VALIDATION OF AN IMAGING-BASED BIOMARKER OF THERAPEUTIC EFFICACY
基于成像的治疗效果生物标志物的开发和验证
- 批准号:
8089501 - 财政年份:2010
- 资助金额:
$ 59.6万 - 项目类别:
DEVELOPMENT AND VALIDATION OF AN IMAGING-BASED BIOMARKER OF THERAPEUTIC EFFICACY
基于成像的治疗效果生物标志物的开发和验证
- 批准号:
7990122 - 财政年份:2010
- 资助金额:
$ 59.6万 - 项目类别:
相似海外基金
Investigating how TRAF1 Controls Inflammasome Activation in Animal Disease Models of Inflammatory Arthritis and Peritonitis
研究 TRAF1 如何控制炎症性关节炎和腹膜炎动物疾病模型中的炎症小体激活
- 批准号:
449429 - 财政年份:2020
- 资助金额:
$ 59.6万 - 项目类别:
Studentship Programs
Establishment of animal disease models for intractable pediatric diseases due to defects of RNA metabolism and development of new therapeutics
RNA代谢缺陷引起的儿科疑难疾病动物模型的建立及新疗法的开发
- 批准号:
20H03644 - 财政年份:2020
- 资助金额:
$ 59.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of type 2 diabetes susceptibility genes using animal disease models
利用动物疾病模型对2型糖尿病易感基因进行功能分析
- 批准号:
18K08466 - 财政年份:2018
- 资助金额:
$ 59.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cell therapy of adipocytes derived from human iPS cells using cellcontainers and animal disease models
使用细胞容器和动物疾病模型对源自人类 iPS 细胞的脂肪细胞进行细胞治疗
- 批准号:
24659444 - 财政年份:2012
- 资助金额:
$ 59.6万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis of genes involved in the pathogenesis of the arthritis using animal disease models..
使用动物疾病模型分析涉及关节炎发病机制的基因。
- 批准号:
17500284 - 财政年份:2005
- 资助金额:
$ 59.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ESTABLISHMENT OF THE DEVELOPING AND SUPPLING SYSTEMS FOR NEW ANIMAL,DISEASE MODELS FROM SUBSPECIES OF THE MOUSE
小鼠亚种新动物、疾病模型的开发和供应体系的建立
- 批准号:
07556128 - 财政年份:1995
- 资助金额:
$ 59.6万 - 项目类别:
Grant-in-Aid for Scientific Research (A)